Welcome to Department of Cancer Immunology
Department head: Professor Johanna Olweus
Deputy department head: Professor Karl-Johan Malmberg
Biomedical laboratory scientist/management: Cathrine Knetter Hoel
Administrative consultant: Peter Wiedswang
“Our goal is to improve cancer diagnostics and therapy through cutting edge research on tumor immunology and lymphocyte biology”
The Department of Cancer Immunology (DCI) has four research groups. Among the PIs, 3 are full professors at UiO, one is visiting professor at Univ of Tunis, and one is also visiting professor at Karolinska Institute.
The research groups in the DCI are partners of: Center of Excellence for Cancer Biomedicine (CCB), K.G. Jebsen Center for Cancer Immunotherapy (JCIT, Director: Olweus) and K.G. Jebsen Center for Inflammation Research (JIRC) and OUH focus area for Cancer Immunotherapy.
The DCI has a strong emphasis on translation and extensive involvement in clinical. The DCI counted 48 members in 2016 (60% women); 10 scientists, 15 postdocs, 10/2 PhD/Master students, and 11 technical staff. Members recruited from Norway/abroad: 54/46%.
The four research groups:
- Olweus lab - Experimental immunotherapy
- Malmberg lab - Natural killer cell biology and cell therapy
- Smeland lab - Lymphoma biology group
- Sioud lab: Immunomodulation and targeted therapies
The group leaders are affiliated with the departments of Molecular Biosciences and Pharmacy at the University of Oslo, where they lecture at undergraduate and graduate courses. Supervision of graduate students and doctoral candidates takes place at the Department of Immunology. Several foreign research fellows and visiting scientists are also associated with the research teams.
|Experimental immunotherapy||Natural killer cell Biology and cell therapy||Lymphoma biology group|
|Immunomodulation and targeted therapies||Cell Signaling and Immune Regulation|